The DOI matches its Crossref record; 330 of the 330 references it cites were found in a registry or an index.
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions
Open accessAbstract
Although Michael acceptors display a potent and broad spectrum of bioactivity, they have largely been ignored in drug discovery because of their presumed indiscriminate reactivity. As such, a dearth of information exists relevant to the thiol reactivity of natural products and their analogues possessing this moiety. In the midst of recently approved acrylamide-containing drugs, it is clear that a good understanding of the hetero-Michael addition reaction and the relative reactivities of biological thiols with Michael acceptors under physiological conditions is needed for the design and use of these compounds as biological tools and potential therapeutics. This Perspective provides information that will contribute to this understanding, such as kinetics of thiol addition reactions, bioactivities, as well as steric and electronic factors that influence the electrophilicity and reversibility of Michael acceptors. This Perspective is focused on α,β-unsaturated carbonyls given their preponderance in bioactive natural products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary clinical studies have shown that osimertinib is capable of inhibiting the L858R mutant of EGFR up to 12 nM, and the IC50 of L858R/T790M mutant was 1 nM.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [132]
In the citing paper
“The inhibition rate of osimertinib against EGFRL858R/T790M mutant was approximately 200-fold higher than that of the wild type.132”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pearson, R. G. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00905a001 · Cited by 10,475
Absolute hardness: companion parameter to absolute electronegativity
Parr, R. G., & Pearson, R. G. (1983) · Journal of the American Chemical Society · doi:10.1021/ja00364a005 · Cited by 7,998
Parr, R. G., von Szentpály, L., & Liu, S. (1999) · Journal of the American Chemical Society · doi:10.1021/ja983494x · Cited by 7,564
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 4,196
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Density functional approach to the frontier-electron theory of chemical reactivity
Parr, R. G., & Yang, W. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00326a036 · Cited by 3,672
Hard and soft acids and bases, HSAB, part 1: Fundamental principles
Pearson, R. G. (1968) · Journal of Chemical Education · doi:10.1021/ed045p581 · Cited by 2,566
Cross, D. A. E., Ashton, S. E., Ghiorghiu, S., Eberlein, C., Nebhan, C. A., Spitzler, P. J., Orme, J. P., Finlay, M. R. V., Ward, R. A., Mellor, M. J., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0337 · Cited by 2,246
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D.-M., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,681
Research works printed but not linked: 6
- Parsons Z. D., 2013, Methods in Enzymology Vol. 528: Hydrogen Peroxide and Cell Signaling Part C, 528, 130
- 2014, FDA Approves Imbruvica to Treat Chronic Lymphocytic Leukemia
- gNodwell, M. B.; Sieber, S. A.Activity-Based Protein Profiling.Springer-Verlag:Berlin, 2012; Vol.324, p165;
- Atsmon J., 1990, Cancer Res., 50, 1879
- Cavalieri E., 2004, Methods in Enzymology, 382, 293
- Geroni C., 2002, Cancer Res., 62, 2332
Cited by
Sorted by citations
Items 301–400 of 618
Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 Mpro
Citarella, A., Moi, D., Pedrini, M., Pérez‐Peña, H., Pieraccini, S., Stagno, C., Micale, N., Schirmeister, T., Sibille, G., Gribaudo, G., et al. (2023) · Molecules · doi:10.3390/molecules28020514 · Cited by 9
Chemical reaction networks based on conjugate additions on β′-substituted Michael acceptors
Spitzbarth, B., & Eelkema, R. (2023) · Chemical Communications · doi:10.1039/d3cc02126b · Cited by 9
Hydrogel Cross-Linking via Thiol-Reactive Pyridazinediones
Bahou, C., Spears, R. J., Rosales, A. M. R., Rochet, L. N. C., Barber, L. J., Stankevich, K. S., Miranda, J. F., Butcher, T., Kerrigan, A., Lazarov, V. K., et al. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00290 · Cited by 9
Altincekic, N., Jores, N., Löhr, F., Richter, C. P., Ehrhardt, C., Blommers, M. J. J., Berg, H., Öztürk, S., Gande, S. L., Linhard, V. L., et al. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.3c00720 · Cited by 9
Natural product-inspired molecules for covalent inhibition of SHP2 tyrosine phosphatase
Liang, W., Krabill, A. D., Gallagher, K. S., Muli, C. S., Qu, Z., Trader, D. J., Zhang, Z., & Dai, M. (2024) · Tetrahedron · doi:10.1016/j.tet.2024.133918 · Cited by 9
Electrophilic Triterpenoid Enones: A Comparative Thiol-Trapping and Bioactivity Study
Prete, D. D., Taglialatela‐Scafati, O., Minassi, A., Sirignano, C., Cruz, C., Bellido, M. L., Muñóz, E., & Appendino, G. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00271 · Cited by 9
Das Cysteinom der Proteinkinasen als Zielstruktur in der Arzneistoffentwicklung
Chaikuad, A., Koch, P., Laufer, S., & Knapp, S. (2017) · Angewandte Chemie · doi:10.1002/ange.201707875 · Cited by 9
Subtel’na, I., Kryshchyshyn‐Dylevych, A., Jia, R., Lelyukh, M. I., Ringler, A., Kubicek, S., Zagrijtschuk, O., Královics, R., & Lesyk, R. (2020) · Archiv der Pharmazie · doi:10.1002/ardp.202000342 · Cited by 9
Hamdy, A. K., Sakamoto, T., Toma, T., Sakamoto, M., Abourehab, M. A. S., Otsuka, M., Fujita, M., Tateishi, H., & Radwan, M. O. (2022) · Pharmaceuticals · doi:10.3390/ph15121579 · Cited by 9
Bjij, I., Khan, S., Ramharack, P., Cherqaoui, D., & Soliman, M. E. S. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28556 · Cited by 9
Kress, B. J., Kim, D. H., Mayo, J. R., Farris, J. T., Heck, B., Sarver, J. G., Andy, D., Trendel, J. A., Heck, B. E., & Erhardt, P. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00560 · Cited by 9
Olekšák, P., Rysanek, D., Vančurová, M., Vašicová, P., Urbancokova, A., Novak, J. F., Maurencova, D., Kashmel, P., Houserova, J., Mikyšková, R., et al. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00190 · Cited by 8
Yuan, H., Guo, Y., Zhang, Z., Sha, H., He, Y., Xu, X., & Hu, W. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10457-x · Cited by 8
Cheng, X., Yu, B.-T., Song, J., Ma, J.-H., Chen, Y., Zhang, C., Tu, P.-H., Muskat, M. N., & Zhu, Z.-G. (2022) · Antioxidants · doi:10.3390/antiox11122406 · Cited by 8
Transition‐Metal‐Catalyzed α,β‐Dehydrogenation of Carbonyl Compounds
Li, Q., Dai, P., Qu, J., & Kang, Y. (2024) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202301267 · Cited by 8
Beleh, O. M., Alomari, S., & Weix, D. J. (2024) · Organic Letters · doi:10.1021/acs.orglett.4c02644 · Cited by 8
Long, M. J. C., Wang, L., & Aye, Y. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7894 · Cited by 8
Gutierrez, L. L. P., Marques, C. V., Scomazzon, S. P., Schroeder, H. T., Fernandes, J. R., Rossato, J. D. S., & de Bittencourt, P. I. H. (2021) · Biochimie · doi:10.1016/j.biochi.2020.12.019 · Cited by 8
Pasqualetto, G., Pileggi, E., Schepelmann, M., Varricchio, C., Rôżanowska, M., Brancale, A., & Bassetto, M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113841 · Cited by 8
Palladium‐Catalyzed Aerobic α,β‐Dehydrogenation of Carboxylic Acids
Shibatani, A., Kataoka, Y., & Ura, Y. (2021) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.202100637 · Cited by 8
Total Synthesis of (±)-Spiroaxillarone A via a Reversible Sulfa-Michael Addition
Long, X., Zhang, M., Yang, X., & Deng, J. (2022) · Organic Letters · doi:10.1021/acs.orglett.1c04282 · Cited by 8
Covalent Modification of the JH2 Domain of Janus Kinase 2
Henry, S. P., Liosi, M.-E., Ippolito, J. A., Menges, F., Newton, A. S., Schlessinger, J., & Jorgensen, W. L. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00414 · Cited by 8
Trifluoromethylcinnamanilide Michael Acceptors for Treatment of Resistant Bacterial Infections
Strhársky, T., Pindjaková, D., Kos, J., Vráblová, L., Šmak, P., Michnová, H., Goněc, T., Hošek, J., Oravec, M., Jendrzejewska, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315090 · Cited by 8
Ting, J. Y. C., Roseli, R. B., & Krenske, E. H. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob02709b · Cited by 8
Measuring and predicting warhead and residue reactivity
Awoonor‐Williams, E., Kennedy, J., & Rowley, C. N. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.09.001 · Cited by 8
Emmetiere, F., Ratnayake, R., Schares, H. A. M., Jones, K. F. M., Bevan–Smith, E., Luesch, H., Harki, D. A., & Grenning, A. J. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202100038 · Cited by 8
Self-citationA Perspective on Covalent Inhibitors: Research and Development Trends of Warheads and TargetsPreprint
Chen, H., Bird, R. E., Wang, D.-S., Diaz, L. M. L., Iyer, K. A., Gustafson, G. R., Kato-Weinstein, J., & Zhou, Q. A. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-wf79n-v2 · Cited by 8
Chemical Proteomics Identifies Ketogenesis‐Mediated Cysteine Modifications Regulating Redox Function
Zhou, Y., Zhang, L., Niu, Z. L., Wang, X., Storper, A., Hunt, R., Zhao, Y., Sharifi, N., & Wang, Z. A. (2026) · Angewandte Chemie International Edition · doi:10.1002/anie.202519830 · Cited by 7
Seven-Step Total Synthesis of Conidiogenone B Enabled by Radical Cyclizations
Bernard, J., Zhang, Z., & Dai, M. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c02334 · Cited by 7
Salin, A. V., Shabanov, A. A., Khayarov, K. R., Ирекович, Н. Р., & Islamov, D. R. (2023) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.3c01223 · Cited by 7
Murai, T., Masaki, Y., & Yasuhara, K. (2024) · Biochemistry · doi:10.1021/acs.biochem.3c00645 · Cited by 7
Industrial Applications of Solid Base Catalysis
Kaur, N., & Banik, N. (2024) · Wiley eBooks · doi:10.1002/9783527846719.ch7 · Cited by 7
Kutsumura, N., Koyama, Y., Saitoh, T., Yamamoto, N., Nagumo, Y., Miyata, Y., Hokari, R., Ishiyama, A., Iwatsuki, M., Otoguro, K., et al. (2020) · Molecules · doi:10.3390/molecules25051112 · Cited by 7
Endothelial TRP channels and cannabinoid receptors are involved in affinin-induced vasodilation
Valencia-Guzmán, C. J., CASTRO-RUÍZ, J. E., García-Gasca, T., Rojas‐Molina, A., Romo‐Mancillas, A., Vázquez, F. J. L., Rojas-Molina, J., & Ibarra‐Alvarado, C. (2021) · Fitoterapia · doi:10.1016/j.fitote.2021.104985 · Cited by 7
Long, M. J. C., Huang, K., & Aye, Y. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00467k · Cited by 7
Magnesium‐Catalyzed Asymmetric Thia‐Michael Addition to α,β‐Unsaturated Ketones
Jaszczewska‐Adamczak, J. A., Baczewska, P., Bujok, R., & Młynarski, J. (2024) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202301414 · Cited by 7
Ganiek, M. A., Ivanova, M. V., Martin, B. R., & Knochel, P. (2018) · Angewandte Chemie · doi:10.1002/ange.201810158 · Cited by 7
Direct Csp 3 –H methylenation of 2-arylacetamides using DMF/Me 2 NH-BH 3 as the methylene source
Liu, Y., Wang, C.-L., Xia, H.-M., Wang, Z., & Wang, Y. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob00875f · Cited by 7
Jiang, Q.-L., Zhu, Z., Shou, P., Teng, F., Zhu, Y., Zhao, H., & Yang, B. (2019) · Phytochemical Analysis · doi:10.1002/pca.2898 · Cited by 7
Doherty, W., Adler, N., Butler, T. J., Knox, A. J. S., & Evans, P. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115774 · Cited by 7
Mol’kova, E. A., Shchegravina, E. S., Otvagin, V. F., Kuzmina, N. S., Malysheva, Y. B., Svirshchevskaya, E. V., Zaburdaeva, E. A., & Fedorov, A. Y. (2022) · Russian Chemical Bulletin · doi:10.1007/s11172-022-3449-7 · Cited by 7
Synthesis and Biological Profile of Omaveloxolone: The Cornerstone for Friedreich Ataxia Treatment
Cordaro, M., Neri, G., Ansari, S. A., Buccheri, R., Scala, A., & Piperno, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199747 · Cited by 6
Basu, R., & Fletcher, S. (2026) · RSC Chemical Biology · doi:10.1039/d5cb00230c · Cited by 6
Discovery of a Covalent Inhibitor Selectively Targeting the Autophosphorylation Site of c-Src Kinase
Zhang, H., Xu, D., Huang, H., Jiang, H., Hu, L., Liu, L., Sun, G., Gao, J., Li, Y., Xia, C., et al. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00048 · Cited by 6
Discovery of new inhibitors of nuclease MRE11
Nikulenkov, F., Carbain, B., Biswas, R., Havel, Š., Prochazkova, J., Sisáková, A., Zacpalova, M., Chavdarova, M., Marini, V., Všianský, V., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117226 · Cited by 6
Sequential Ytterbium(III) Triflate Catalyzed One‐Pot Three‐Component Thia‐Michael Addition
Huang, H., & Liang, C. (2018) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.201800087 · Cited by 6
Li, W., Zhang, J., Lu, S. K., Cheng, G., Wan, W., & Wang, L. (2023) · Tetrahedron Letters · doi:10.1016/j.tetlet.2023.154506 · Cited by 6
Ninck, S., Halder, V., Krahn, J. H., Beißer, D., Resch, S., Dodds, I., Scholtysik, R., Bormann, J., Sewald, L., Gupta, M. D., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00322 · Cited by 6
Chatir, E., David, A. H. G., Gapin, A., & Goujon, A. (2024) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202400211 · Cited by 6
Meirelles, M. A., Braga, C. B., Ornelas, C., & Pilli, R. A. (2019) · ChemMedChem · doi:10.1002/cmdc.201900281 · Cited by 6
Novel advances in biotransformation and bioactivation research—2019 year in review
Khojasteh, S. C., Driscoll, J. P., Jackson, K. D., Miller, G. P., Mitra, K., Rietjens, I. M. C. M., & Zhang, D. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1772281 · Cited by 6
Thiol Reactivity of N-Aryl α-Methylene-γ-lactams: Influence of the Guaianolide Structure
Dempe, D. P., Ji, C., Liu, P., & Brummond, K. M. (2022) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.2c01530 · Cited by 6
Self-citationSynthesis and structure–activity relationship of berkeleylactone A-derived antibiotics
Malatinský, T., Valachová, D., Pinčeková, L., Scherhaufer, D., Olejníková, P., Májeková, M., Vargova, J., Gaálová, B., Bujdáková, H., Nováčiková, J., et al. (2022) · Organic & Biomolecular Chemistry · doi:10.1039/d2ob01452a · Cited by 6
Jin, S., Sun, X., Liu, D., Xie, H., & Rao, Y. (2019) · Chemical Papers · doi:10.1007/s11696-019-00686-0 · Cited by 6
The literature of heterocyclic chemistry, part XVII, 2017
Belen’kii, L. I., & Evdokimenkova, Y. B. (2019) · Advances in heterocyclic chemistry · doi:10.1016/bs.aihch.2019.01.003 · Cited by 6
Bai, B., Tu, P.-H., Weng, J., Zhang, Y., Lin, Q., Muskat, M. N., Wang, J., Tang, X., & Cheng, X. (2025) · Antioxidants · doi:10.3390/antiox14050546 · Cited by 5
Continuous-flow electrochemical benzylic dehydrogenation of arylalkanes to arylalkenes
Du, X.-X., He, S., Li, D., Jiang, Y., Zhu, C., & Shen, T. (2025) · Green Chemistry · doi:10.1039/d5gc01442e · Cited by 5
Kinetic Modeling of Covalent Inhibition: Effects of Rapidly Fluctuating Intermediate States
Ghaby, K., & Roux, B. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00952 · Cited by 5
Luu, P. V., Phan, T.-T. T., Pham, N.-T., Le, H.-G., Chen, L.-Y., Ton-Nu, H. L., Lee, M., Shen, Y., Fan, Y., Chang, Y., et al. (2025) · Phytochemistry · doi:10.1016/j.phytochem.2025.114756 · Cited by 5
Pise, S., & Dey, N. (2026) · Journal of Materials Chemistry B · doi:10.1039/d5tb02823j · Cited by 5
Employment of Michael addition reactions for the functionalization of carboranes
Rys, E. G., Alpatova, V. M., Kononova, E. G., Smol’yakov, A. F., Константинович, М. С., & Ol’shevskaya, V. A. (2022) · New Journal of Chemistry · doi:10.1039/d2nj03509j · Cited by 5
Zheng, P., Deng, Y., He, J., Sun, Z., Liu, Y., Fan, X., & Cao, S. (2024) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.202300608 · Cited by 5
Phenylpropynones as Selective Disulfide Rebridging Bioconjugation Reagents
Maes, D., Nicque, M., Iftikhar, M., & Winne, J. M. (2024) · Organic Letters · doi:10.1021/acs.orglett.3c04160 · Cited by 5
Antiviral Activity of Curcuminoids Derived from Deverra tortuosa Plant
Elsharkawy, E. R., Alqurashi, M. M., Alshathly., M., & Huq, A. M. (2024) · Journal of Food Biochemistry · doi:10.1155/2024/5548871 · Cited by 5
Co‐Catalyzed Dehydrogenation Claisen Condensation of Secondary Alcohols with Esters†
Gao, S., Hao, W., Ji, Y., Li, X., Zhang, C., & Zhang, G. (2024) · Chinese Journal of Chemistry · doi:10.1002/cjoc.202400481 · Cited by 5
Chaudhuri, S., Rogers, D. M., Hayes, C. J., Inzani, K., & Hirst, J. D. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01379 · Cited by 5
Citarella, A., Petrella, S., Moi, D., Dimasi, A., Braga, T., Ruberto, L., Pieraccini, S., Sironi, M., Micale, N., Schirmeister, T., et al. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117987 · Cited by 5
Classifying covalent protein binders by their targeted binding site
Bedewy, W. A., Mulawka, J. W., & Adler, M. J. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.130067 · Cited by 5
Maram, L., Michael, J. M., Politte, H., Srirama, V. S., Hadji, A., Habibi, M., Kelly, M. O., Brookheart, R. T., Finck, B. N., Hegazy, L., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117150 · Cited by 5
Synthesis and Investigation of Tricyclic Isoquinoline Derivatives as Antibacterial Agents
Phillips, M. J. A., Ung, A. T., Harry, E. J., Ashmore, J., & McDonagh, A. M. (2024) · BioChem · doi:10.3390/biochem5010001 · Cited by 5
Novel Maleimide Linkers Based on a Piperazine Motif for Strongly Increased Aqueous Solubility
Dijkstra, M., Schueffl, H. H., Federa, A., Kast, C., Unterlercher, A., Keppler, B. K., Heffeter, P., & Kowol, C. R. (2025) · ACS Omega · doi:10.1021/acsomega.4c10825 · Cited by 5
Chalcones: Potential Anticancer Agents
McCluskey, A., & Russell, C. C. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.91441 · Cited by 5
Hitting the Bullseye: Endogenous Electrophiles Show Remarkable Nuance in Signaling Regulation
Long, M. J. C., Herrera, P. A. M., & Aye, Y. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00006 · Cited by 5
Lee, S. B., Yu, J., Kim, H., Kim, K. W., Jeong, J. W., Kim, Y. L., Park, S. J., Koo, T., Lee, C., Hong, K. B., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01926 · Cited by 5
Recent Developments on the Earth-Abundant-Metal-Catalyzed α,β-Dehydrogenation of Carbonyl Compounds
Dai, P., Kang, Y., Li, Q., & Qu, J. (2023) · Synthesis · doi:10.1055/a-2232-8882 · Cited by 5
Kiattisewee, C., Kaidad, A., Jiarpinitnun, C., & Luanphaisarnnont, T. (2018) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-018-2175-1 · Cited by 5
Covalent Janus Kinase 3 Inhibitors
Gehringer, M., & Förster, M. (2020) · Topics in medicinal chemistry · doi:10.1007/7355_2020_96 · Cited by 5
Reheim, M. A. M. A., Hafiz, I. S. A., & Sophy, M. A. E. (2020) · Current Organic Synthesis · doi:10.2174/1570179417666200628021125 · Cited by 5
Hosoya, T., Shukla, N. M., Fujita, Y., Yao, S., Lao, F. S., Baba, H., Yasuda, S., Cottam, H. B., Carson, D. A., Hayashi, T., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.607713 · Cited by 5
Synthesis and bioactivity studies of covalent inhibitors derived from (-)-Chaetominine
Zhou, X., Feng, X., Wang, D., Chen, D., Wu, G., Yan, Z., Lyu, X., Wang, H., Yang, J.-M., & Zhao, Y. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130694 · Cited by 5
Zheng, S., Wang, L., Xiong, J., Liang, G., Xu, Y., & Fu, L. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00948 · Cited by 5
Zhang, M., Wang, P., Liu, H., Wang, D., Deng, Y., Bai, Y., Luo, F., Wu, W., & Chen, T. (2023) · ChemSusChem · doi:10.1002/cssc.202300583 · Cited by 5
Self-amplified activatable nanophotosensitizers for HIF-1α inhibition-enhanced photodynamic therapy
Guo, Z., Wang, N., He, X., Shen, J., Yang, X., Xie, C., Fan, Q., & Zhou, W. J. (2024) · Nanoscale · doi:10.1039/d3nr05245a · Cited by 5
Trachsel, A., Leocata, S., Laumer, J. D. S., & Herrmann, A. (2024) · Helvetica Chimica Acta · doi:10.1002/hlca.202400046 · Cited by 4
Discovery of RMC-6291, a potent, orally bioavailable, covalent RAS(ON) G12C selective inhibitor
Cregg, J., Pota, K., Gill, A. L., & Koltun, E. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21861-3.00006-1 · Cited by 4
Exploiting Avidity Effects for the Discovery of Low Affinity Protein-Binding Fragments
Jayalath, I. M., Beckwith, D. M., Yoon, J., Liu, X., & Kodadek, T. J. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01742 · Cited by 4
Goda, M. N., Alqarni, L. S., Algethami, F. K., Ibrahim, H., El‐Wekil, M. M., Ali, R., Almahmoud, S. A., & Ali, A. B. H. (2026) · RSC Advances · doi:10.1039/d6ra02905a · Cited by 4
Anti-Cancer Potential of a new Derivative of Caffeic Acid Phenethyl Ester targeting the Centrosome
Giordano, C., Kendler, J., Sexl, M., Kollman, S., Varenicja, M., Szabó, B., Timelthaler, G., Kirchhofer, D., Hollóczki, O., Turner, S. D., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103582 · Cited by 4
Townsend, P. A., Farrar, E. H. E., & Grayson, M. N. (2022) · ACS Omega · doi:10.1021/acsomega.2c03739 · Cited by 4
Use of nucleophilic compounds, and their combination, for acrylamide removal
Zamora, R., & Hidalgo, F. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99119-3.00004-7 · Cited by 4
de Paula, H., Bolsoni, C. S., de Souza, F. F., Fonseca, V. R., Romão, W., de Sairre, M. I., Honório, K. M., Lacerda, V., & Morais, P. A. B. (2024) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70016 · Cited by 4
Inhibition mechanism of cathepsin B by curcumin molecule: a DFT study
Mary, C. P. V., Vijayakumar, S., & Shankar, R. (2019) · Theoretical Chemistry Accounts · doi:10.1007/s00214-018-2410-1 · Cited by 4
Zenta, F., Soekamto, N. H., Dali, S., Firdausiah, S., Rasyid, H., Bahriah, B., Agustan, A., & Tahir, D. (2022) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-022-02499-7 · Cited by 4
Sun, L., Loey, A. M. V., Buvé, C., & Michiels, C. W. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04877-22 · Cited by 4
Systematic Targeting of Protein Complexes with Molecular COUPLrs
Yang, D., Harry, S. A., Chong, H. B., Khandelwal, N., Zhang, E., Nordenfelt, N. S., Chen, N. J., Lee, C., Kaluziak, S. T., Codd, E. M., et al. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-2314 · Cited by 4
Franz, M., Mörchen, B., Degenhart, C., Gülden, D., Shkura, O., Wolters, D. A., Koch, U., Klebl, B., Stoll, R., Helfrich, I., et al. (2021) · ChemMedChem · doi:10.1002/cmdc.202100167 · Cited by 4
Li, X., Zhang, H., Dong, S., Gao, X., Sun, H., Zhou, Z., Hu, K., Guo, S., Zhang, Q., Guo, Z., et al. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117843 · Cited by 3
Meehan, M. C., Scofield, G. E., Stahl, C. E., Wolfe, J. A., Horne, W. S., Liu, P., & Brummond, K. M. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00833 · Cited by 3
Self-citationCollective Total Synthesis of a Unique Class of Liverworts‐Derived Cembrane Diterpenoids
Hermann, A., & Fürstner, A. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202518836 · Cited by 3
Lobo, F., de la Lastra, J. M. P., Andrés, C. M. C., Bustamante‐Munguira, E., Andrés, C., & Pérez‐Lebeña, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311390 · Cited by 3
Metadata
- Authors
- Jackson, P. A., Widen, J. C., Harki, D. A., & Brummond, K. M.
- Affiliations
- University of Pittsburgh (US)
- University of Minnesota (US)
- Corresponding author
- Harki, Daniel A.
- Brummond, Kay M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-12-20
- Volume
- 60
- Issue
- 3
- Pages
- 839-885
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- PMC
- PMC5308545
- OpenAlex
- W2564708666
- Cited by
- 588
- References
- 329
- Citations by year
- 2026: 88 · 2025: 71 · 2024: 80 · 2023: 51 · 2022: 58 · 2021: 74 · 2020: 72 · 2019: 51 · 2018: 27 · 2017: 15
- FWCI
- 14.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01-GM054161, R01-GM110129)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Physical Organic Chemistry and Reaction Kinetics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Reactivity of Sulfur-Containing Compounds
- Keywords
- α,β-unsaturated carbonyl compounds, Michael acceptors, hetero-Michael addition, thiol reactivity, acrylamide, electrophilicity, reaction kinetics, steric and electronic effects, natural products, drug design, biological activity
- MeSH terms
- Humans, Ketones, Sulfhydryl Compounds, Drug Design, Cell Line, Tumor, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
